logo

For the Inventor, By the Inventor

Cambridge, MA, United States of America

Scifluor Life Sciences, Inc.

Calculating rank
USPTO Granted Patents = 23

% Expired Patents = 43.5


Trademarks = 1

Forward Citations = 126

Loading Chart...
Loading Chart...

6 inventors (with patents filed for the assignee):

goldMedal Takeru Furuya (22 out of 29 patents)

silverMedal Ben C Askew (17 out of 52 patents)

bronzeMedal Mark E Duggan (12 out of 79 patents)

4.  D Scott Edwards (9 out of 12 patents)

5.  Richard Wayne Heidebrecht, Jr (8 out of 17 patents)

6.  Ajay Purohit (2 out of 19 patents)

7.  Yakeru Furuya (0 patent)

8.  D Scott Edward (0 patent)


23 patents:

1. 10752625 - Method of making tetrahydronaphthyridinyl nonanoic acid compounds (2020-08-25),
2. 10676437 - Fluorinated 4-(substituted amino)phenyl carbamate derivatives (2020-06-09),
3. 10308647 - Fused imidazole derivatives as IDO/TDO inhibitors (2019-06-04),
4. 10301307 - Fluorinated tetrahydronaphthyridinyl nonanoic acid derivatives and uses thereof (2019-05-28),
5. 10253025 - Method of making tetrahydronaphthyridinyl nonanoic acid compounds (2019-04-09),
6. 10155758 - Fluorinated 3-(2-oxo-3-(3-arylpropyl)imidazolidin-1-yl)-3-arylpropanoic acid derivatives (2018-12-18),
7. 10118929 - Nonanoic and decanoic acid derivatives and uses thereof (2018-11-06),
8. 10106537 - Fluorinated integrin antagonists (2018-10-23),
9. 9895340 - Fluorinated benzofuran derivatives (2018-02-20),
10. 9802933 - Fluorinated 3-(2-oxo-3-(3-arylpropyl)imidazolidin-1-yl)-3-arylpropanoic acid derivatives (2017-10-31),
11. 9790222 - Fluorinated tetrahydronaphthyridinyl nonanoic acid derivatives and uses thereof (2017-10-17),
12. 9717729 - Fluorinated integrin antagonists (2017-08-01),
13. 9662331 - 3-aryl-2-((arylamino)methyl)quinazolin-4-(3H)-ones (2017-05-30),
14. 9624189 - Fluorinated benzofuran derivatives (2017-04-18),
15. 9624169 - Aryl- and heteroaryl-pyrrolidine-2-carboxamide compounds (2017-04-18),
Company Overview
Scifluor Life Sciences, Inc. is a biotechnology company based in Cambridge, MA, specializing in the development of innovative solutions for the pharmaceutical and life sciences sectors. The company focuses on the synthesis of advanced fluorinated compounds, which play a crucial role in enhancing the efficacy and safety of therapeutic agents. Scifluor's expertise lies in leveraging cutting-edge chemistry to address complex challenges in drug development, contributing to the advancement of healthcare and therapeutic innovations.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

23 Patents

#123 in Cambridge, MA

#870 in Massachusetts

#14,456 in US

#27,744 in the World

Cambridge, MA (US)
Cambridge, MA, United States of America

Scifluor Life Sciences, Inc.

Forward Citations = 126

6 inventors:

goldMedal Takeru Furuya (22 out of 29 patents)

silverMedal Ben C Askew (17 out of 52 patents)

bronzeMedal Mark E Duggan (12 out of 79 patents)

4.  D Scott Edwards (9 out of 12 patents)

5.  Richard Wayne Heidebrecht, Jr (8 out of 17 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Scifluor Life Sciences, Inc.. Retrieved from https://idiyas.com/company/scifluor-life-sciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…